Report Detail
Global and United States Remicade Biosimilar Market Insights, Forecast to 2026
- RnM4201613 |
- 11 September, 2020 |
- Global |
- 125 Pages |
- QYResearch |
- Pharma & Healthcare
Remicade Biosimilar market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Remicade Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Remicade Biosimilar market is segmented into
100mg/10ml
500mg/50ml
Segment by Application, the Remicade Biosimilar market is segmented into
Blood Disorders
Oncology Diseases
Regional and Country-level Analysis
The Remicade Biosimilar market is analysed and market size information is provided by regions (countries).
The key regions covered in the Remicade Biosimilar market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Remicade Biosimilar Market Share Analysis
Remicade Biosimilar market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Remicade Biosimilar business, the date to enter into the Remicade Biosimilar market, Remicade Biosimilar product introduction, recent developments, etc.
The major vendors covered:
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
1 Study Coverage
- 1.1 Remicade Biosimilar Product Introduction
- 1.2 Market Segments
- 1.3 Key Remicade Biosimilar Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Remicade Biosimilar Market Size Growth Rate by Type
- 1.4.2 100mg/10ml
- 1.4.3 500mg/50ml
- 1.5 Market by Application
- 1.5.1 Global Remicade Biosimilar Market Size Growth Rate by Application
- 1.5.2 Blood Disorders
- 1.5.3 Oncology Diseases
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Remicade Biosimilar Market Size, Estimates and Forecasts
- 2.1.1 Global Remicade Biosimilar Revenue 2015-2026
- 2.1.2 Global Remicade Biosimilar Sales 2015-2026
- 2.2 Global Remicade Biosimilar, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Remicade Biosimilar Historical Market Size by Region (2015-2020)
- 2.3.1 Global Remicade Biosimilar Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Remicade Biosimilar Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Remicade Biosimilar Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Remicade Biosimilar Sales Forecast by Region (2021-2026)
- 2.4.2 Global Remicade Biosimilar Revenue Forecast by Region (2021-2026)
3 Global Remicade Biosimilar Competitor Landscape by Players
- 3.1 Global Top Remicade Biosimilar Sales by Manufacturers
- 3.1.1 Global Remicade Biosimilar Sales by Manufacturers (2015-2020)
- 3.1.2 Global Remicade Biosimilar Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Remicade Biosimilar Manufacturers by Revenue
- 3.2.1 Global Remicade Biosimilar Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Remicade Biosimilar Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Remicade Biosimilar Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Remicade Biosimilar Revenue in 2019
- 3.2.5 Global Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Remicade Biosimilar Price by Manufacturers
- 3.4 Global Remicade Biosimilar Manufacturing Base Distribution, Product Types
- 3.4.1 Remicade Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Remicade Biosimilar Product Type
- 3.4.3 Date of International Manufacturers Enter into Remicade Biosimilar Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Remicade Biosimilar Market Size by Type (2015-2020)
- 4.1.1 Global Remicade Biosimilar Sales by Type (2015-2020)
- 4.1.2 Global Remicade Biosimilar Revenue by Type (2015-2020)
- 4.1.3 Remicade Biosimilar Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Remicade Biosimilar Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Remicade Biosimilar Sales Forecast by Type (2021-2026)
- 4.2.2 Global Remicade Biosimilar Revenue Forecast by Type (2021-2026)
- 4.2.3 Remicade Biosimilar Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Remicade Biosimilar Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Remicade Biosimilar Market Size by Application (2015-2020)
- 5.1.1 Global Remicade Biosimilar Sales by Application (2015-2020)
- 5.1.2 Global Remicade Biosimilar Revenue by Application (2015-2020)
- 5.1.3 Remicade Biosimilar Price by Application (2015-2020)
- 5.2 Remicade Biosimilar Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Remicade Biosimilar Sales Forecast by Application (2021-2026)
- 5.2.2 Global Remicade Biosimilar Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Remicade Biosimilar Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
- 6.1 United States Remicade Biosimilar Market Size YoY Growth 2015-2026
- 6.1.1 United States Remicade Biosimilar Sales YoY Growth 2015-2026
- 6.1.2 United States Remicade Biosimilar Revenue YoY Growth 2015-2026
- 6.1.3 United States Remicade Biosimilar Market Share in Global Market 2015-2026
- 6.2 United States Remicade Biosimilar Market Size by Players (International and Local Players)
- 6.2.1 United States Top Remicade Biosimilar Players by Sales (2015-2020)
- 6.2.2 United States Top Remicade Biosimilar Players by Revenue (2015-2020)
- 6.3 United States Remicade Biosimilar Historic Market Review by Type (2015-2020)
- 6.3.1 United States Remicade Biosimilar Sales Market Share by Type (2015-2020)
- 6.3.2 United States Remicade Biosimilar Revenue Market Share by Type (2015-2020)
- 6.3.3 United States Remicade Biosimilar Price by Type (2015-2020)
- 6.4 United States Remicade Biosimilar Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 United States Remicade Biosimilar Sales Forecast by Type (2021-2026)
- 6.4.2 United States Remicade Biosimilar Revenue Forecast by Type (2021-2026)
- 6.4.3 United States Remicade Biosimilar Price Forecast by Type (2021-2026)
- 6.5 United States Remicade Biosimilar Historic Market Review by Application (2015-2020)
- 6.5.1 United States Remicade Biosimilar Sales Market Share by Application (2015-2020)
- 6.5.2 United States Remicade Biosimilar Revenue Market Share by Application (2015-2020)
- 6.5.3 United States Remicade Biosimilar Price by Application (2015-2020)
- 6.6 United States Remicade Biosimilar Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 United States Remicade Biosimilar Sales Forecast by Application (2021-2026)
- 6.6.2 United States Remicade Biosimilar Revenue Forecast by Application (2021-2026)
- 6.6.3 United States Remicade Biosimilar Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Remicade Biosimilar Market Size YoY Growth 2015-2026
- 7.2 North America Remicade Biosimilar Market Facts & Figures by Country
- 7.2.1 North America Remicade Biosimilar Sales by Country (2015-2020)
- 7.2.2 North America Remicade Biosimilar Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Remicade Biosimilar Market Size YoY Growth 2015-2026
- 8.2 Europe Remicade Biosimilar Market Facts & Figures by Country
- 8.2.1 Europe Remicade Biosimilar Sales by Country
- 8.2.2 Europe Remicade Biosimilar Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Remicade Biosimilar Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Remicade Biosimilar Market Facts & Figures by Country
- 9.2.1 Asia Pacific Remicade Biosimilar Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Remicade Biosimilar Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Remicade Biosimilar Market Size YoY Growth 2015-2026
- 10.2 Latin America Remicade Biosimilar Market Facts & Figures by Country
- 10.2.1 Latin America Remicade Biosimilar Sales by Country
- 10.2.2 Latin America Remicade Biosimilar Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Remicade Biosimilar Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Remicade Biosimilar Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Remicade Biosimilar Sales by Country
- 11.2.2 Middle East and Africa Remicade Biosimilar Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Synthon Pharmaceuticals
- 12.1.1 Synthon Pharmaceuticals Corporation Information
- 12.1.2 Synthon Pharmaceuticals Description and Business Overview
- 12.1.3 Synthon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Synthon Pharmaceuticals Remicade Biosimilar Products Offered
- 12.1.5 Synthon Pharmaceuticals Recent Development
- 12.2 LG Life Sciences
- 12.2.1 LG Life Sciences Corporation Information
- 12.2.2 LG Life Sciences Description and Business Overview
- 12.2.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 LG Life Sciences Remicade Biosimilar Products Offered
- 12.2.5 LG Life Sciences Recent Development
- 12.3 Novartis (Sandoz)
- 12.3.1 Novartis (Sandoz) Corporation Information
- 12.3.2 Novartis (Sandoz) Description and Business Overview
- 12.3.3 Novartis (Sandoz) Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Novartis (Sandoz) Remicade Biosimilar Products Offered
- 12.3.5 Novartis (Sandoz) Recent Development
- 12.4 Celltrion
- 12.4.1 Celltrion Corporation Information
- 12.4.2 Celltrion Description and Business Overview
- 12.4.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Celltrion Remicade Biosimilar Products Offered
- 12.4.5 Celltrion Recent Development
- 12.5 Biocon
- 12.5.1 Biocon Corporation Information
- 12.5.2 Biocon Description and Business Overview
- 12.5.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Biocon Remicade Biosimilar Products Offered
- 12.5.5 Biocon Recent Development
- 12.6 Hospira
- 12.6.1 Hospira Corporation Information
- 12.6.2 Hospira Description and Business Overview
- 12.6.3 Hospira Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 Hospira Remicade Biosimilar Products Offered
- 12.6.5 Hospira Recent Development
- 12.7 Merck Serono (Merck Group)
- 12.7.1 Merck Serono (Merck Group) Corporation Information
- 12.7.2 Merck Serono (Merck Group) Description and Business Overview
- 12.7.3 Merck Serono (Merck Group) Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 Merck Serono (Merck Group) Remicade Biosimilar Products Offered
- 12.7.5 Merck Serono (Merck Group) Recent Development
- 12.8 Biogen idec Inc.
- 12.8.1 Biogen idec Inc. Corporation Information
- 12.8.2 Biogen idec Inc. Description and Business Overview
- 12.8.3 Biogen idec Inc. Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Biogen idec Inc. Remicade Biosimilar Products Offered
- 12.8.5 Biogen idec Inc. Recent Development
- 12.9 Genentech (Roche Group)
- 12.9.1 Genentech (Roche Group) Corporation Information
- 12.9.2 Genentech (Roche Group) Description and Business Overview
- 12.9.3 Genentech (Roche Group) Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 Genentech (Roche Group) Remicade Biosimilar Products Offered
- 12.9.5 Genentech (Roche Group) Recent Development
- 12.11 Synthon Pharmaceuticals
- 12.11.1 Synthon Pharmaceuticals Corporation Information
- 12.11.2 Synthon Pharmaceuticals Description and Business Overview
- 12.11.3 Synthon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Synthon Pharmaceuticals Remicade Biosimilar Products Offered
- 12.11.5 Synthon Pharmaceuticals Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Remicade Biosimilar Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Remicade Biosimilar Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Remicade Biosimilar. Industry analysis & Market Report on Remicade Biosimilar is a syndicated market report, published as Global and United States Remicade Biosimilar Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Remicade Biosimilar market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
